← Back to headlines
Bicara Therapeutics Reports GAAP EPS of -$0.68 and Releases Q4 Earnings Highlights
Bicara Therapeutics has announced its Generally Accepted Accounting Principles (GAAP) Earnings Per Share (EPS) at -$0.68, with Q4 earnings call highlights providing further details on its financial performance.
30 Mar, 13:19 — 30 Mar, 14:15
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
Yahoo
Center
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
Coverage Timeline
First report: seeking-alpha · 30 Mar, 13:19|Full coverage: 2 · 56m|Window: 56m
Left-leaningCenterRight-leaning
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
DENR Partners with NGO to Restore Mangrove Areas in Tacloban
just now
Philippine Pharma Companies Reaffirm Medicine Price Freeze Until June Amid Middle East Crisis
just now
Philippine National Oil Co. Seeks P8-B Fuel Budget for Reserves
just now